Gastric Cancer and Microbiota: The Complex Role of the Microbiome in Carcinogenesis and Treatment Strategies

Strategic Insights -

Researchers have detailed new data on gastric cancer, highlighting the complex interplay between the microbiota and the development of the disease. According to a study published in the Journal of Life, the composition of the gastric microbiota plays a significant role in shaping the gastric microenvironment and influencing disease progression. The study suggests that microbial profiles can serve as both prognostic biomarkers and therapeutic targets, and that emerging strategies such as probiotics, dietary interventions, and fecal microbiota transplantation (FMT) offer new avenues for restoring microbial balance and enhancing therapy response.

Key Takeaways:

  • Gastric cancer remains a major global health burden, with high morbidity and mortality rates, particularly in regions with prevalent Helicobacter pylori (H. pylori) infection.
  • The gastric microbiota plays a complex role in carcinogenesis, including disruption of mucosal integrity, activation of oncogenic signaling pathways, and epigenetic alterations.
  • Microbial metabolites, such as short-chain fatty acids, secondary bile acids, and lactate, play dual roles in promoting or suppressing tumorigenesis.
  • Oral and gut-derived microbes, translocated to the gastric niche, have been implicated in reshaping the gastric microenvironment and exacerbating disease progression.
  • The composition of the microbiota influences responses to cancer immunotherapy, suggesting that microbial profiles can serve as both prognostic biomarkers and therapeutic targets.
  • Emerging strategies, such as probiotics, dietary interventions, and FMT, offer new avenues for restoring microbial balance and enhancing therapy response.
  • The study emphasizes the potential of microbiome modulation in both preventive and therapeutic frameworks.

Statistics:

  • Gastric cancer is a major global health burden, with high morbidity and mortality rates (Life, 2025).
  • Helicobacter pylori (H. pylori) infection is a major risk factor for gastric cancer, particularly in regions with high prevalence (Life, 2025).
  • The gastric microbiota plays a complex role in carcinogenesis, with alterations in the microbial community contributing to chronic inflammation, immune modulation, and epithelial transformation (Life, 2025).
  • Microbial metabolites, such as short-chain fatty acids, secondary bile acids, and lactate, play dual roles in promoting or suppressing tumorigenesis (Life, 2025).
  • Oral and gut-derived microbes, translocated to the gastric niche, have been implicated in reshaping the gastric microenvironment and exacerbating disease progression (Life, 2025).

Sources:

  • Gastric Cancer and Microbiota: Exploring the Microbiome's Role in Carcinogenesis and Treatment Strategies. Life, 2025,15(7):999. (Life - http://www.mdpi.com/journal/life)
  • NewsRx. "Victor Babes" University of Medicine and Pharmacy of Timisoara Researchers Release New Data on Gastric Cancer (Gastric Cancer and Microbiota: Exploring the Microbiome's Role in Carcinogenesis and Treatment Strategies). Immunotherapy Weekly. August 13, 2025; p 169.